<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC 2024 19_11-12_513</article-id>
<article-id pub-id-type="doi">10.15836/ccar2024.513</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
<subj-group subj-group-type="subheading"><subject>Cardiovascular prevention and rehabilitation</subject></subj-group>
</article-categories>
<title-group>
<article-title>Cardiopulmonary exercise testing outcomes of 3-week intensified cardiac rehabilitation in patients with heart failure and coronary artery disease: a single centre pilot study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6238-3738</contrib-id><name><surname>Travica Samsa</surname><given-names>Dijana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0379-5235</contrib-id><name><surname>Skro&#x010D;e</surname><given-names>Kristina</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3349-0395</contrib-id><name><surname>Ivani&#x0161;</surname><given-names>Viktor</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-1968-8954</contrib-id><name><surname>Brajdi&#x0107; &#x0160;&#x0107;ulac</surname><given-names>Ana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0001-0236-0128</contrib-id><name><surname>Per&#x0161;i&#x0107;</surname><given-names>Ivana</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1050-0135</contrib-id><name><surname>Uravi&#x0107; Bursa&#x0107;</surname><given-names>Iva</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7462-054X</contrib-id><name><surname>Raki&#x0107;</surname><given-names>Marijana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7763-726X</contrib-id><name><surname>Mileti&#x0107; Gr&#x0161;kovi&#x0107;</surname><given-names>Silvija</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4473-5431</contrib-id><name><surname>Per&#x0161;i&#x0107;</surname><given-names>Viktor</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<aff id="aff1"><label>1</label><institution>&#x0422;halassotherapia Opatija - Specialized hospital for medical rehabilitation of cardiac, pulmonary and rheumatic diseases</institution>, <addr-line>Opatija</addr-line>, <country country="hr">Croatia</country></aff>
<aff id="aff2"><label>2</label><institution>University of Rijeka</institution>, <institution content-type="dept">Faculty of Medicine</institution>, <addr-line>Rijeka</addr-line>, <country country="hr">Croatia</country></aff>
<aff id="aff3"><label>3</label><institution>University of Rijeka</institution>, <institution content-type="dept">Faculty of Health Studies</institution>, <addr-line>Rijeka</addr-line>, <country country="hr">Croatia</country>,</aff>
<aff id="aff4"><label>4</label><institution>Josip Juraj Strossmayer University of Osijek</institution>, <institution content-type="dept">Faculty of dental medicine and health</institution>, <addr-line>Osijek</addr-line>, <country country="hr">Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Dijana Travica Samsa, &#x0422;halassotherapia Opatija, Mar&#x0161;ala Tita 188/1, HR-51410 Opatija, Croatia. / Phone: +385-91-1621-778 / E-mail: <email xlink:href="dijana.travica.samsa@uniri.hr">dijana.travica.samsa@uniri.hr</email></corresp></author-notes>
<pub-date date-type="pub" publication-format="electronic"><month>11</month><year>2024</year></pub-date>
<pub-date date-type="pub" publication-format="print"><month>11</month><year>2024</year></pub-date>
<volume>19</volume>
<issue>11-12</issue>
<fpage>513</fpage>
<lpage>513</lpage>
<history>
<date date-type="received"><day>07</day><month>10</month><year>2024</year></date>
<date><day>31</day><month>10</month><year>2024</year></date>
</history>
<permissions>
<copyright-statement>Croatian Cardiac Society</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>KEYWORDS: </title><kwd>cardiopulmonary exercise testing</kwd><kwd>cardiac rehabilitation</kwd><kwd>coronary heart disease</kwd><kwd>heart failure</kwd><kwd>exercise prescription</kwd></kwd-group>
</article-meta>
</front>
<body>
<p><bold>Introduction</bold>: Cardiopulmonary exercise testing (CPET) is the gold standard for evaluating cardiovascular functional capacity. It provides assessment of the integrative exercise responses involving pulmonary, cardiovascular and skeletal muscle systems. CPET integrates different variables that support the understanding of physiological and pathophysiological mechanisms. Moreover, it provides a remarkable tool for monitoring the cardiac rehabilitation program (CR) and the effect of therapy. Clinical decision-making and recommendations for its application are continuously evolving every year. In patients with chronic heart failure (HF), physical activity is one of the main components of CR (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>), although the training structure is not clearly defined. Many parameters are used to classify the intensity of physical activity (RPE, MET, %HRpeak, %Wpeak) (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>). Still, &#x201C;threshold-based&#x201D; classification, determined regarding the first and second ventilatory thresholds (VT), VT1 and VT2, is considered as the optimal for improving individual&#x2019;s functional capacity (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>).</p>
<p><bold>Patients and Methods</bold>: A pilot project of 8 patients with HF (HFrEF, HFimpEF) with underlying coronary artery disease (CAD) (age 65 &#x00B1; 6 yrs; VO<sub>2</sub>peak 15.4 &#x00B1; 2.7 ml min-1 kg-1, EF 42&#x00B1;9%) underwent CR for 3 weeks. Functional capacity (VO<sub>2</sub>peak) and all corresponding cardiopulmonary parameters were assessed using CPET at the program&#x2019;s beginning and end. The training zones were prescribed and adjusted according to the parameters obtained in the CPET. Aerobic continuous training (ACT) of moderate-intensity was carried out for all patients.</p>
<p><bold>Results</bold>: Peak VO<sub>2</sub> significantly increased by 9% (15.4 &#x00B1; 2.7 vs. 16.9 &#x00B1; 2.6 ml min-1 kg-1, p=.001, d=1.93) after 3 weeks of training. At the same time point, VT1 and VT2 significantly improved by 12% (9.6 &#x00B1; 2.6 vs. 10.8 &#x00B1; 3.0 ml min-1 kg-1, p=.005, d=1.43) and 12% (13.5 &#x00B1; 3.3 vs. 15.0 &#x00B1; 2.4 ml min-1 kg-1, p=.011, d=1.21).</p>
<p><bold>Conclusion</bold>: A 3-week ACT program is sufficient to induce significant functional adaptations visible in VO<sub>2</sub> peak and VO<sub>2</sub> improvements at VT1 and VT2 in patients with HF, provided that patients are trained at the same volume but at an individually defined intensity. Further research is needed to define if volume or intensity (ACT vs HIIT, High-Intensity Interval Training) is the key parameter that induces significant functional improvements in CAD patients with HFrEF in 3-week CR.</p>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dibben</surname><given-names>GO</given-names></name><name><surname>Hannay</surname><given-names>JR</given-names></name><name><surname>Taylor</surname><given-names>RS</given-names></name></person-group>. <article-title>Exercise training in heart failure.</article-title> <source>Heart</source>. <year>2024</year> February 12;<volume>110</volume>(<issue>5</issue>):<fpage>373</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1136/heartjnl-2022-321132</pub-id><pub-id pub-id-type="pmid">37460196</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visseren</surname><given-names>FLJ</given-names></name><name><surname>Mach</surname><given-names>F</given-names></name><name><surname>Smulders</surname><given-names>YM</given-names></name><name><surname>Carballo</surname><given-names>D</given-names></name><name><surname>Koskinas</surname><given-names>KC</given-names></name><name><surname>B&#x00E4;ck</surname><given-names>M</given-names></name><etal/></person-group> <article-title>ESC National Cardiac Societies; ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.</article-title> <source>Eur Heart J</source>. <year>2021</year> September 7;<volume>42</volume>(<issue>34</issue>):<fpage>3227</fpage>&#x2013;<lpage>337</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehab484</pub-id><pub-id pub-id-type="pmid">34458905</pub-id></mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>D</given-names></name><name><surname>Abreu</surname><given-names>A</given-names></name><name><surname>Ambrosetti</surname><given-names>M</given-names></name><name><surname>Cornelissen</surname><given-names>V</given-names></name><name><surname>Gevaert</surname><given-names>A</given-names></name><name><surname>Kemps</surname><given-names>H</given-names></name><etal/></person-group> <article-title>Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology.</article-title> <source>Eur J Prev Cardiol</source>. <year>2022</year> February 19;<volume>29</volume>(<issue>1</issue>):<fpage>230</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1093/eurjpc/zwab007</pub-id><pub-id pub-id-type="pmid">34077542</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
